drugset / Trial / NCT02570932

Administration of Expanded Autologous Adult Bone Marrow Mesenchymal Cells in Established Chronic Spinal Cord Injuries

NCT02570932 ↗

Phase 2 Completed 10 enrolled Puerta de Hierro University Hospital
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to analyze the potential clinical efficacy of intrathecal administration, in the subarachnoid space, of in vitro expanded autologous adult bone marrow mesenchymal stem cells in the treatment of patients with established chronic spinal cord injury (LEM).

Timeline

Start
2015-07
Primary completion
2017-12-04
Completion
2017-12-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous Mesenchymal Bone Marrow Cell Cell therapy 100 cells Intrathecal

Indications